Source:http://linkedlifedata.com/resource/pubmed/id/10384147
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1999-7-15
|
pubmed:abstractText |
It is well established that melanoma cells express Ags that are recognized by autologous T cells in vitro. Tumor-infiltrating lymphocytes in situ comprise clonotypic T cells, suggesting that their expansion is driven by Ag stimulation. Still, little is known about the detailed characteristics of the in situ T cell response. In the present study, we scrutinized this response by analyzing multiple metastatic lesions for the presence of clonotypic T cells. This approach was chosen to distinguish whether the clonal T cell expansion occurs as a systemic or localized phenomenon. TCR clonotype mapping of six s.c. metastases from two patients revealed the presence of multiple (from 40 to >60) clonotypic T cells in all lesions. Clonotypic T cells were present in TCR beta-variable regions expressed both at high and low levels. Comparison of the T cell clonotypes present in different lesions from individual patients demonstrated that, in general, clonotypes were exclusively detected in a single lesion. Hence, anti-melanoma T cell responses are much more heterogeneous than previously anticipated and accommodate a predominance of strictly localized T cell clonotypes.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Neoplasm,
http://linkedlifedata.com/resource/pubmed/chemical/Melanoma-Specific Antigens,
http://linkedlifedata.com/resource/pubmed/chemical/Neoplasm Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Antigen, T-Cell...,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0022-1767
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
163
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
443-7
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:10384147-Antigens, Neoplasm,
pubmed-meshheading:10384147-Cell Differentiation,
pubmed-meshheading:10384147-Clone Cells,
pubmed-meshheading:10384147-Electrophoresis, Polyacrylamide Gel,
pubmed-meshheading:10384147-Humans,
pubmed-meshheading:10384147-Lymphocyte Count,
pubmed-meshheading:10384147-Lymphocytes, Tumor-Infiltrating,
pubmed-meshheading:10384147-Melanoma,
pubmed-meshheading:10384147-Melanoma-Specific Antigens,
pubmed-meshheading:10384147-Neoplasm Proteins,
pubmed-meshheading:10384147-Receptors, Antigen, T-Cell, alpha-beta,
pubmed-meshheading:10384147-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:10384147-Sequence Analysis, DNA,
pubmed-meshheading:10384147-Skin Neoplasms,
pubmed-meshheading:10384147-T-Lymphocyte Subsets,
pubmed-meshheading:10384147-Transcription, Genetic,
pubmed-meshheading:10384147-Tumor Markers, Biological
|
pubmed:year |
1999
|
pubmed:articleTitle |
In situ T cell responses against melanoma comprise high numbers of locally expanded T cell clonotypes.
|
pubmed:affiliation |
Department of Tumor Cell Biology, Institute of Cancer Biology, Danish Cancer Society, Copenhagen. ps@cancer.dk
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|